Correlation of MRI lesions with visual psychophysical deficit in secondary progressive multiple sclerosis

Brain

Volumn 123, Issue 7, 2000, Pages 1471-1480

  Caruana, P A ^a,b   Davies, M Brendan ^a,b   Weatherby, S J M ^a,b   Williams, R ^c   Haq, N ^c   Foster, D H ^b,d   Hawkins, C P ^a,b  

^a Royal Infirmary   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c Keele Multiple Sclerosis Res Group   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chromatic; Magnocellular parvocellular; MRI; Multiple sclerosis; Visual psychophysics

Indexed keywords

ADULT; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; MAGNOCELLULAR NUCLEUS; MALE; MORPHOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC NERVE; PRIORITY JOURNAL; SENSORY DYSFUNCTION; VISUAL SYSTEM;

EID: 0033919972     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.7.1471     Document Type: Article

References (64)

1. Baizer JS, Ungerleider LG, Desimone R. Organization of visual inputs to the inferior temporal and posterior parietal cortex in macaques. J Neurosci 1991; 11: 168-90.
2. Barkhof F, Scheltens P, Valk J, Waalewijn C, Uitdehaag BM, Polman CH. Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using gadolinium-'enhanced' STIR imaging. Neuroradiology 1991; 33: 70-1.
3. Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 1987; 50: 125-33.
4. Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993; 111: 773-5.
5. Casagrande VA. A third parallel visual pathway to primate area V1. [Review]. Trends Neurosci 1994; 17: 305-10.
6. Dain SJ, Rammohan KW, Benes SC, King-Smith PE. Chromatic, spatial, and temporal losses of sensitivity in multiple sclerosis. Invest Ophthalmol Vis Sci 1990; 31: 548-58.
7. Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 1998, 40: 765-70.
8. DeYoe EA, Van Essen DC. Concurrent processing streams in monkey visual cortex. [Review]. Trends Neurosci 1988; 11: 219-26.
9. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall; 1993.
10. Fallowfield L, Krauskopf J. Selective loss of chromatic sensitivity in demyelinating disease. Invest Ophthalmol Vis Sci 1984; 25: 771-3.
11. Ferrera VP, Nealey TA, Maunsell JH. Mixed parvocellular and magnocellular geniculate signals in visual area V4. Nature 1992; 358: 756-61.
12. Filippi M, Horsfield MA, Bressi S, Martinelli V, Baratti C, Reganati P, et al. Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain 1995; 118: 1593-600.
13. Foster DH. Psychophysical loss in optic neuritis: luminance and colour aspects. In: Hess RF, Plant GT, editors. Optic neuritis. Cambridge: Cambridge University Press; 1986. p. 152-91.
14. Foster DH, Bischof WF. Thresholds from psychometric functions: superiority of bootstrap to incremental and probit variance estimators. Psychol Bull 1991; 109: 152-9.
15. Foster DH, Snelgar RS, Heron JR. Abnormal chromatic and luminance sensitivity in multiple sclerosis [abstract]. Electroencephalogr Clin Neurophysiol 1983; 56: 16P.
16. Foster DH, Snelgar RS, Heron JR. Nonselective losses in foveal chromatic and luminance sensitivity in multiple sclerosis. Invest Ophthalmol Vis Sci 1985; 26: 1431-41.
17. Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI, et al. Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology 1996; 38: 317-21.
18. Glynn RJ, Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol 1992; 110: 381-7.
19. Grimaud J, Barker GJ, Wang L, Lai M, MacManus DG, Webb SL, et al. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study. J Neurol 1999; 246: 961-7.
20. Halliday AM, McDonald WI, Mushin J. Visual evoked response in diagnosis of multiple sclerosis. Br Med J 1973; 4: 661-4.
21. Hawkins CP, Munro PM, MacKenzie F, Kesselring J, Tofts PS, du Boulay EP, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990; 113: 365-78.
22. Herbst H, Ketabi A, Thier P, Dichgans J. Comparison of psychophysical and evoked potential methods in the detection of visual deficits in multiple sclerosis. Electroencephalogr Clin Neurophysiol 1997; 104: 82-90.
23. Hornabrook RS, Miller DH, Newton MR, MacManus DG, du Boulay EP, Halliday AM, et al. Frequent involvement of the optic radiation in patients with acute isolated optic neuritis. Neurology 1992; 42: 77-9.
24. Ingling CR Jr, Martinez-Uriegas E. The relationship between spectral sensitivity and spatial sensitivity for the primate r-g X-channel. Vision Res 1983; 23: 1495-500.
25. Kapoor R, Miller DH, Jones SJ, Plant GT, Brusa A, Gass A, et al. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 1998; 50: 230-7.
26. Mason RJ, Snelgar RS, Foster DH, Heron JR, Jones RE. Abnormalities of chromatic and luminance critical flicker frequency in multiple sclerosis. Invest Ophthalmol Vis Sci 1982; 23: 246-52.
27. Maunsell JH, Nealey TA, DePriest DD. Magnocellular and parvocellular contributions to responses in the middle temporal visual area (MT) of the macaque monkey. J Neurosci 1990; 10: 3323-34.
28. Maunsell JH, Ghose GM, Assad JA, McAdams CJ, Boudreau CE, Noerager BD. Visual response latencies of magnocellular and parvocellular LGN neurons in macaque monkeys. Vis Neurosci 1999; 16: 1-14.
29. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. [Review]. J Neurol Neurosurg Psychiatry 1992; 55: 747-52.
30. Merigan WH, Katz LM, Maunsell JH. The effects of parvocellular lateral geniculate lesions on the acuity and contrast sensitivity of macaque monkeys. J Neurosci 1991; 11: 994-1001.
31. Miller DH. The spectrum of abnormalities in multiple sclerosis. In: Muller DH, Kesselring J, McDonald WI, Paty DW, Thompson AJ, editors. Magnetic resonance in multiple sclerosis. Cambridge: Cambridge University Press; 1997. p. 31-62.
32. Miller DH, Rudge P, Johnson G, Kendall BE, MacManus DG, Moseley IF, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988; 111: 927-39.
33. Miller NR, editor. Walsh and Hoyt's clinical neuro-ophthalmology. 4th edn. Baltimore: Williams and Wilkins; 1982. p. 69-86.
34. Mullen KT. The contrast sensitivity of human colour vision to red-green and blue-yellow chromatic gratings. J Physiol (Lond) 1985; 359: 381-400.
35. Mullen KT, Plant GT. Colour and luminance vision in human optic neuritis. Brain 1986; 109: 1-13.
36. Nealey TA, Maunsell JH. Magnocellular and parvocellular contributions to the responses of neurons in macaque striate cortex. J Neurosci 1994; 14: 2069-79.
37. Ormerod IE, McDonald WI, du Boulay EP, Kendall BE, Moseley IF, Halliday AM, et al. Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry 1986; 49: 124-7.
38. Ormerod IE, Miller DH, McDonald WI, du Boulay EP, Rudge P, Kendall BE, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987; 110: 1579-616.
39. Patterson VH, Heron JR. Visual field abnormalities in multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43: 205-9.
40. Perkin GD, Rose FC, editors. Optic neuritis and its differential diagnosis. Oxford: Oxford University Press; 1979.
41. Phillips ML, Foster DH, Honan WP, Edgar GK, Heron JR. Optic neuritis. Differential losses of luminance and chromatic function near a scotoma. Brain 1994; 117: 767-73.
42. Plant GT. Disorders of colour vision in diseases of the nervous system. In: Foster DH, editor. Inherited and acquired colour vision deficiencies. Vision and visual dysfunction, Vol. 7. Basingstoke (UK): Macmillan; 1991. p. 173-98.
43. Plant GT, Hess RF. Temporal frequency discrimination in optic neuritis and multiple sclerosis. Brain 1985; 108: 647-76.
44. Plant GT, Hess RF. Regional threshold contrast sensitivity within the central visual field in optic neuritis. Brain 1987; 110: 489-515.
45. Plant GT, Kermode AG, Turano G, Moseley IF, Miller DH, MacManus DG, et al. Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging. Neurology 1992; 42: 68-76.
46. Porciatti V, Sartucci F. Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis. Brain 1996; 119: 723-40.
47. Poser S, Wikstrom J, Bauer HJ. Clinical data and identification of special forms of multiple sclerosis in 1271 cases studied with a standardised documentation system. J Neurol Sci 1979; 40: 159-68.
48. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
49. Regan D, Kothe AC, Sharpe JA. Recognition of motion-defined shapes in patients with multiple sclerosis and optic neuritis. Brain 1991; 114: 1129-55.
50. Russell MH, Murray IJ, Metcalfe RA, Kulikowski JJ. The visual defect in multiple sclerosis and optic neuritis. A combined psychophysical and electrophysiological investigation. Brain 1991; 114: 2419-35.
51. Schiller PH, Logothetis NK, Charles ER. Parallel pathways in the visual system: their role in perception at isoluminance. Neuropsychologia 1991; 29: 433-41.
52. Shapley R. Visual sensitivity and parallel retinocortical channels. [Review]. Annu Rev Psychol 1990; 41: 635-58.
53. Silveira LC, Perry VH. The topography of magnocellular projecting ganglion cells (M-ganglion cells) in the primate retina. Neuroscience 1991; 40: 217-37.
54. Snelgar RS, Foster DH, Heron JR, Jones RE, Mason RJ. Multiple sclerosis: abnormalities in luminance, chromatic, and temporal function at multiple retinal sites. Doc Ophthalmol 1985; 60: 79-92.
55. Taylor MM, Creelman CD. PEST: efficient estimates on probability functions. J Acoust Soc Am 1967; 41: 782-7.
56. Travis D, Thompson P. Spatiotemporal contrast sensitivity and colour vision in multiple sclerosis. Brain 1989; 112: 283-303.
57. Ulrich J, Groebke-Lorenz W. The optic nerve in multiple sclerosis: a morphological study with retrospective clinico-pathological correlations. Neuro-ophthalmology 1983; 3: 149-59.
58. van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, et al. Correlating MR imaging and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short-TE (T1-weighted) spin-echo images. Neurology 1995; 45: 1684-90.
59. van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50: 1282-8.
60. Vleugels L, Van Nunen A, Lafosse C, Ketelaer P, Vandenbussche E. Temporal and spatial resolution in foveal vision of multiple sclerosis patients. Vision Res 1998; 38: 2987-97.
61. Wall M. Loss of P retinal ganglion cell function in resolved optic neuritis. Neurology 1990; 40: 649-53.
62. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-50.
63. Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063-6.
64. Zisman F, King-Smith PE, Bhargava SK. Spectral sensitivities of acquired color defects analyzed in terms of color opponent theory. Mod Probl Ophthalmol 1978; 19: 254-7.